209 related articles for article (PubMed ID: 32063125)
1. Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
Aldiwani H; Zaya M; Suppogu N; Quesada O; Johnson BD; Mehta PK; Shufelt C; Petersen J; Azarbal B; Samuels B; Anderson RD; Shaw LJ; Kar S; Handberg E; Kelsey SF; Pepine CJ; Bairey Merz CN
J Am Heart Assoc; 2020 Feb; 9(4):e013168. PubMed ID: 32063125
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Doyle M; Weinberg N; Pohost GM; Bairey Merz CN; Shaw LJ; Sopko G; Fuisz A; Rogers WJ; Walsh EG; Johnson BD; Sharaf BL; Pepine CJ; Mankad S; Reis SE; Vido DA; Rayarao G; Bittner V; Tauxe L; Olson MB; Kelsey SF; Biederman RW
JACC Cardiovasc Imaging; 2010 Oct; 3(10):1030-6. PubMed ID: 20947048
[TBL] [Abstract][Full Text] [Related]
3. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
[TBL] [Abstract][Full Text] [Related]
4. Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).
Kenkre TS; Malhotra P; Johnson BD; Handberg EM; Thompson DV; Marroquin OC; Rogers WJ; Pepine CJ; Bairey Merz CN; Kelsey SF
Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29217675
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
[TBL] [Abstract][Full Text] [Related]
6. Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.
Bakir M; Nelson MD; Jones E; Li Q; Wei J; Sharif B; Minissian M; Shufelt C; Sopko G; Pepine CJ; Merz CNB
Int J Cardiol; 2016 Nov; 223():936-939. PubMed ID: 27589041
[TBL] [Abstract][Full Text] [Related]
7. Stable angina in women: lessons from the National Heart, Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation.
Merz CN; Shaw LJ
J Cardiovasc Med (Hagerstown); 2011 Feb; 12(2):85-7. PubMed ID: 21228716
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.
Shaw LJ; Merz CN; Pepine CJ; Reis SE; Bittner V; Kip KE; Kelsey SF; Olson M; Johnson BD; Mankad S; Sharaf BL; Rogers WJ; Pohost GM; Sopko G;
Circulation; 2006 Aug; 114(9):894-904. PubMed ID: 16923752
[TBL] [Abstract][Full Text] [Related]
9. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.
Gulati M; Cooper-DeHoff RM; McClure C; Johnson BD; Shaw LJ; Handberg EM; Zineh I; Kelsey SF; Arnsdorf MF; Black HR; Pepine CJ; Merz CN
Arch Intern Med; 2009 May; 169(9):843-50. PubMed ID: 19433695
[TBL] [Abstract][Full Text] [Related]
10. Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: the Women's Ischemia Syndrome Evaluation (WISE) Study.
Krantz DS; Olson MB; Francis JL; Phankao C; Bairey Merz CN; Sopko G; Vido DA; Shaw LJ; Sheps DS; Pepine CJ; Matthews KA
J Womens Health (Larchmt); 2006 Dec; 15(10):1214-23. PubMed ID: 17199462
[TBL] [Abstract][Full Text] [Related]
11. TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Petersen JW; Johnson BD; Kip KE; Anderson RD; Handberg EM; Sharaf B; Mehta PK; Kelsey SF; Merz CN; Pepine CJ
PLoS One; 2014; 9(5):e96630. PubMed ID: 24800739
[TBL] [Abstract][Full Text] [Related]
12. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
Pauly DF; Johnson BD; Anderson RD; Handberg EM; Smith KM; Cooper-DeHoff RM; Sopko G; Sharaf BM; Kelsey SF; Merz CN; Pepine CJ
Am Heart J; 2011 Oct; 162(4):678-84. PubMed ID: 21982660
[TBL] [Abstract][Full Text] [Related]
13. Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Eastwood JA; Johnson BD; Rutledge T; Bittner V; Whittaker KS; Krantz DS; Cornell CE; Eteiba W; Handberg E; Vido D; Bairey Merz CN
J Womens Health (Larchmt); 2013 Sep; 22(9):724-32. PubMed ID: 23992103
[TBL] [Abstract][Full Text] [Related]
14. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
[TBL] [Abstract][Full Text] [Related]
15. Influence of symptom typicality for predicting MACE in patients without obstructive coronary artery disease: From the CONFIRM Registry (Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry).
Lee JH; Han D; Hartaigh BÓ; Gransar H; Lu Y; Rizvi A; Park MW; Roudsari HM; Stuijfzand WJ; Berman DS; Callister TQ; DeLago A; Hadamitzky M; Hausleiter J; Al-Mallah MH; Budoff MJ; Kaufmann PA; Raff G; Chinnaiyan K; Cademartiri F; Maffei E; Villines TC; Kim YJ; Leipsic J; Feuchtner G; Pontone G; Andreini D; Marques H; Rubinshtein R; Achenbach S; Shaw LJ; Chang HJ; Bax J; Chow B; Cury RC; Gomez M; Jones EC; Lin FY; Min JK; Peña JM
Clin Cardiol; 2018 May; 41(5):586-593. PubMed ID: 29521447
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
[TBL] [Abstract][Full Text] [Related]
17. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics, Sex Differences, and Outcomes in Patients With Normal or Near-Normal Coronary Arteries, Non-Obstructive or Obstructive Coronary Artery Disease.
Ouellette ML; Löffler AI; Beller GA; Workman VK; Holland E; Bourque JM
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720503
[TBL] [Abstract][Full Text] [Related]
20. Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation).
Sedlak T; Herscovici R; Cook-Wiens G; Handberg E; Wei J; Shufelt C; Bittner V; Reis SE; Reichek N; Pepine C; Bairey Merz CN
J Am Heart Assoc; 2020 Apr; 9(7):e013234. PubMed ID: 32268814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
